Evidence map›Paper›PMID 38125940›Full record

ArticleFrontiers in oncology2023

The prevalence rate, mortality, and 5-year overall survival of

Xue-Fei Liu, Shuai Ju, Ke-Ying Wang, Ying Li, Jin-Wei Qiang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xue-Fei Liu *Department of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Shuai Ju *Departments of Interventional Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Ke-Ying Wang *Department of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Ying LiDepartment of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Jin-Wei QiangDepartment of Radiology, Jinshan Hospital, Fudan University, Shanghai, China.
Jinshan Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Only a few studies have focused on the association between Methods: From January 20, 2018, to January 31, 2021, 5,866 inpatients were included in the study. A total of 656 Results: Lung cancer was found the most common malignancy, accounting for 18.6% of all malignancies, followed by colorectal, stomach, liver, and gallbladder cancers. These five leading malignancies accounted for approximately 61.8% of all cases. Colorectal cancer was the leading cause of malignancy death, followed by lung, stomach, gallbladder, and liver cancers. These five leading causes of death accounted for approximately 55.6% of all death cases. Statistical significance was found in the prevalence rate between Conclusion:

Indexed as

cancerfive-year overall survivalmortalityprevalenceSchistosoma japonicum

Identifiers

PMID38125940
PMCPMC10731309
OpenAlexW4389392995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.